Datavault AI (DVLT), Wellgistics Health Expand Partnership to Launch Blockchain-Powered HaaS Model
Published: 31 Mar 2026
Author: Precedence Research
Datavault AI Inc is a provider of data monetization, credentialing, digital engagement, and real-world asset tokenization technologies. It builds on its existing PharmacyChain technology, which digitises the tracking of prescription drugs from script to fulfilment.
It announced plans to expand its blockchain-enabled smart contracts partnership.
According to Towards Healthcare, the Blockchain in Pharmaceutical market is projected to experience significant growth, with estimates suggesting the market size will increase from USD 1.43 billion in 2026 to approximately USD 11.23 billion by 2035, representing a compound annual growth rate (CAGR) of 25.7% from 2026 to 2035. Growth of the Blockchain in Pharmaceutical market is driven by increasing need for supply chain transparency, rising concerns over counterfeit drugs, enhanced data security requirements, regulatory compliance demands, growing adoption of digital technologies, and improved traceability and efficiency across pharmaceutical operations globally.
President & Interim-CEO of Wellgistics Health, Prashant Patel, stated partnership with NFL Alumni Health allows us to have confidence that we have a trusted partner capable of reaching and motivating patients to take greater control over their healthcare.
About Datavault AI
The company was formerly known as WiSA Technologies, Inc. and changed its name to Datavault AI Inc. in February 2025.
It is a cloud-based platform that provides comprehensive solutions with a collaborative focus in its Acoustic Science and Data Science Divisions. The company also offers data technology and software solutions that enable customers to thrive in the evolving landscape of data ownership, privacy, and security through high-performance computing (HPC) infrastructure and proprietary software. Datavault AI's technology is customizable and offers AI and Machine Learning (ML) automation, third-party integration, detailed analytics and data, marketing automation, and advertising monitoring.
Forward-Looking Statements
Datavault AI has commercial partnerships, including, without limitation, with Sports Illustrated, which are necessarily based upon estimates and assumptions that, while considered reasonable by the Company and its management. The forward-looking statements made in this relate only to events as of the date on which the statements are made. Datavault AI's forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, or investments.
A recent report by Towards Healthcare highlights that the Blockchain in Pharmaceutical market is gaining momentum, driven by increasing need for transparency, enhanced security, and efficient data management, with growing adoption across supply chain, clinical trials, and regulatory processes supporting industry-wide digital transformation initiatives.